KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in IntangiblesChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Change in Receivables: 2018-2020

Historic Change in Receivables for BioNTech SE (BNTX) over the last 2 years, with Dec 2020 value amounting to $65.1 million.

  • BioNTech SE's Change in Receivables rose 1387.13% to $65.1 million in Q4 2020 from the same period last year, while for Dec 2020 it was $1.7 million, marking a year-over-year increase of 540.61%. This contributed to the annual value of -$295,552 for FY2020, which is 9185.12% down from last year.
  • Per BioNTech SE's latest filing, its Change in Receivables stood at $65.1 million for Q4 2020, which was up 223.62% from -$52.7 million recorded in Q3 2020.
  • Over the past 5 years, BioNTech SE's Change in Receivables peaked at $65.1 million during Q4 2020, and registered a low of -$52.7 million during Q3 2020.
  • Over the past 3 years, BioNTech SE's median Change in Receivables value was -$2.3 million (recorded in 2020), while the average stood at $1.9 million.
  • Data for BioNTech SE's Change in Receivables shows a peak YoY increase of 1,387.13% (in 2020) and a maximum YoY decrease of 151,275.91% (in 2020) over the last 5 years.
  • BioNTech SE's Change in Receivables (Quarterly) stood at $14.7 million in 2018, then crashed by 134.39% to -$5.1 million in 2019, then soared by 1,387.13% to $65.1 million in 2020.
  • Its last three reported values are $65.1 million in Q4 2020, -$52.7 million for Q3 2020, and -$8.5 million during Q2 2020.